Announcing the first enterprise intervention platform for metabolic disease prevention and reversal. Read press release here.
Company

Together, Solving the Metabolic Problem at Scale.

Journeys Metabolic™ is a pioneer in the development of physician-led metabolic disease interventions for health systems, providers, and patients.

Precision Patient Journey

Long-Term 
Behavior Change

Fully
Interoperable

Mission

We are driven to be the conduit to end the metabolic crisis at scale.

Vision

Empower patients and their providers to enhance care and optimize value-based outcomes with the ultimate goal of transforming the quality of life for all.

Our vision is access to scalable, long-term metabolic health gains for all communities, especially underserved groups that may have received little to no support up to this point.

Leadership Team

Our leadership team includes experienced healthcare executives, metabolic health providers, and clinical experts dedicated to making an impact on the metabolic crisis.

Jim Howard

CEO & CoFounder

Jim Howard is a 29-year healthtech executive and founder of Journeys Metabolic in 2023 after four years as cofounder and CEO of legacy company Readout Health, raising launch capital and incubating the project as an EIR with Biogenerator Ventures in St. Louis. Prior to Readout Health, Jim cofounded and was the initial CEO of Washington University-spinout SentiAR, the first AR platform for interventional procedures. He previously led a team of 50 as a commercial VP of at CareFusion’s through the acquisition by Becton Dickinson in 2015. Jim was a first-five employee and VP of Global Sales at digital health startup Pharmacy OneSource, acquired by Wolters Kluwer Health in 2010. He is a board director at POC medical device company, MagBiosense, and is passionate about metabolic disease reversal for both clinical and financial implications.
Read Bio

Courtney Younglove, MD

Chief Medical Officer

Dr. Courtney Younglove is Journeys Metabolic's Chief Medical Officer. Board-certified in both Obesity Medicine and Obstetrics and Gynecology, she is one of only seventy fellows of the Obesity Medicine Association. She has practiced medicine in the greater Kansas City area for over twenty years and has practiced Obesity Medicine since 2014. Dr. Younglove founded Heartland Weight Loss, the first insurance-based Obesity Medicine clinic in greater Kansas City. Under her leadership, the practice has experienced considerable growth, currently serving thousands of patients every month.

Dr. Younglove’s passion for cost-effective, evidence-based treatment of obesity and chronic disease is apparent in every facet of her life. In addition to creating a reproducible framework to guide the clinical care of patients with excess weight and using this framework to help thousands of patients, Dr. Younglove often lectures to groups of clinicians and clinicians-in-training about obesity treatment. She also sits on the board of SPEC*KC, an independent physician network that partners directly with self-insured employers to improve price transparency and reduce the cost of claims. During the course of her career, Dr. Younglove has received many awards, including being named one of the “Best Doctors in America” five separate times, as featured in the Kansas City Business Journal. At Journeys Metabolic, she provides overall clinical protocol direction and manages clinical implementations with our value-based care partners.

Read Bio

Greg Robinson, PhD

Chief Technology Officer

Greg Robinson, PhD is our CTO at Journey'sMetabolic and is passionate about value-based healthcare and improving the lives of patients in need. He most recently led AI product development, technology, and data operations at Relias, with a focus on products for clinicians and health systems. Prior to that role, he was the Chief Data and Analytics Officer for Marshfield Clinic Health System, responsible for the development of strategy and tactical execution of data as an asset for the Marshfield Clinic Health System. Greg was co-founder of a health IT software in the predictive modeling space and has held senior executive and consultant roles leading technology and operations for healthcare organizations for academic medical centers and health plans. He holds a PhD from the University of California at Berkeley and is an active auto enthusiast and racer.

Read Bio

Jessica Yang, DNP

Head of Clinical Product

Jessica Yang, DNP, serves as the Head of Clinical Product at Journeys Metabolic. She brings a rich background of over nineteen years in nursing and clinical product management, with her career spanning both academic medicine and innovative early-stage companies. Jessica is deeply committed to revolutionizing patient care by supporting individuals throughout their health journey, enhancing the integration of technology in clinical settings, and tackling complex healthcare challenges.

Most recently at Medically Home, she led the evolution of a product from its initial MVP stage to full maturity, facilitating hospital-level care in patients' homes. Prior to this, she dedicated over a decade at Massachusetts General Hospital, specializing as a clinical nurse specialist and registered nurse. Her focus areas included acute care medicine/surgery, informatics, and efforts to minimize patient readmissions. Jessica earned her Doctorate in Nursing Practice from Northeastern University. Beyond her professional pursuits, she is an avid runner and enjoys all winter sports.

Read Bio

Steve Edwards

Chief Strategy Officer

Steve Edwards serves as the Chief Strategy Officer at Journeys Metabolic after three decades of acute care leadership. He is passionately focused on transforming the traditional model of healthcare toward prevention through innovative technology and virtual platforms.

Steve retired from CoxHealth after 30 years of service where he held a multitude of leadership roles, culminating in his decade-long tenure as President and CEO of the $1.9 B Missouri-based health system.

While President at CoxHealth, Steve shepherded the health system through a period of significant growth and transformation, enlarging the employee base from 7,500 to 12,500, adding hospitals, clinics and insurance companies. Under his leadership CoxHealth won distinctions for quality, economic development, information technology, nursing care and employee satisfaction. The organization has been recognized five consecutive years by Forbes Magazine as a leading place to work. CoxHealth made huge swings in market share and sharply increased its profitability, liquidity and balance sheet during Steve’s tenure.

Steve completed a post graduate fellowship at Baylor University Medical Center, holds a Masters of Health Administration from the Washington University School of Medicine, and a B.S. from Drury University.

Read Bio

David Mait

Head of Marketing

David is our Head of Marketing at Journeys Metabolic. Over his 15+ years as a senior healthcare marketer, he has helped fast-growing digital health companies level-up their marketing function + team, accelerate growth pipeline, and communicate their brand story + offerings to prospects, customers and the world.

David formerly held lead marketing roles at Heartbeat Health (virtual cardiology), Quartet Health (behavioral health) and Castlight Health (healthcare transparency). In addition to healthcare, he has acted as a Fractional Chief Marketing Officer for a diverse set of B2B and B2C venture-backed software companies. David completed his Masters in International Relations at the Maxwell School of Citizenship at Syracuse University and his BA at Lehigh University. He loves being outdoors and is a passionate Miami Dolphins and A.S. Roma fan.

Read Bio

Advisors

We are advised by cutting-edge thinkers in metabolic and population health from some of the world's leading institutions.

Robert Lustig, MD

UCSF
Neuroendocrinologist

Dr. John Mattison, MD 

Former Kaiser
Permanente CMIO

Open Positions

5+ Years of Data

Clinical Outcomes

At Journeys Metabolic™, we offer an intervention protocol backed by more than 5 years of clinical data showing long-lasting results. Our physician-developed program has helped thousands of patients lose weight, manage their blood glucose, and lower their blood pressure through easy-to-use technology. 

In our clinical trial, we saw significant improvements in depression, anxiety and sleep quality through standardized, evidence-based assessments, PHQ-9, GAD-7, and PSQI respectively.
8
%
 Body Weight Reduction
17
%
HbA1c Reduction
8
%
Systolic Blood Pressure Reduction
30
%
Triglyceride Reduction
54
%
NAFLD Resolution
8
%
Average Weight Loss
Over a five-year period, Journeys Metabolic™ assisted patients in reducing their weight through long-term behavior change.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
17
%
HbA1c Reduction
Journeys Metabolic™ has helped patients systematically lower their blood glucose levels over the course of a five-year period.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
8
%
Systolic Blood Pressure Reduction
Through the Journeys Metabolic™ program, patients have been able to reduce their systolic blood pressure over the past five years.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
30
%
Triglyceride Reduction
Triglyceride levels among Journeys Metabolic™patients have dropped significantly over a five-year period.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
54
%
NAFLD Resolution
Over a five-year period, Journeys Metabolic™ achieved remarkable success in facilitating NAFLD resolution through comprehensive lifestyle modifications and sustainable behavioral changes.


Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
Research & Insights

The Journeys Blog

Access the latest insights, research, and updates on metabolic health at our Journeys Blog.

Digital Therapeutic Interventions: A Solution for Provider Burnout

We know how exhausting it is to be a healthcare provider in today’s challenging environment. You face many demands and pressures that can take a toll on your […]
Read More

Non-Alcoholic Fatty Liver Disease (NAFLD): What You Need to Know

Did you know that your liver may be storing too much fat even if you don’t drink alcohol? This condition, called nonalcoholic fatty liver disease NAFLD, is the […]
Read More

Being Metabolically Healthy: Why Does It Matter?

Metabolic health has become an increasingly important and relevant topic in the clinical  field. Understanding and promoting metabolic health is an opportunity to serve our patients better. What […]
Read More
Font Size
crosschevron-downchevron-leftchevron-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram